Trademark: 97503974
Status Date
Wednesday, January 10, 2024
Filing Date
Thursday, July 14, 2022
Published for Opposition
Tuesday, June 6, 2023
5 Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation such as autoimmune and neurodegenerative diseases
Jan 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2024
Sou Extension 1 Granted
Jan 10, 2024
Sou Extension 1 Filed
Jan 10, 2024
Sou Teas Extension Received
Aug 1, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Published For Opposition
May 17, 2023
Notification Of Notice Of Publication E-Mailed
May 3, 2023
Approved For Pub - Principal Register
Apr 28, 2023
Assigned To Examiner
Aug 4, 2022
New Application Office Supplied Data Entered
Jul 18, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24